
BioNTech and Ryvu Therapeutics enter into global collaboration
BioNTech SE and Ryvu Therapeutics S.A. announced that the companies have entered into a multi-target research collaboration targeting immune...

Collaboration to develop mRNA vaccine against betacoronaviruses
Ethris GmbH a German company specialising in the development of mRNA vaccines, announced their collaboration with DIOSynVax Ltd., an English biotech...

Lonza collaborates with Asher Biotherapeutics Inc
Asher Biotherapeutics is a developer of targeted immunotherapies for cancer, chronic viral infections and autoimmune disorders. AB248, Asher Bio’s...

Cultimate Foods UG raises €700.000 in pre-seed financing
Berlin food-tech specialist Cultimate Foods UG has raised €700.000 in a pre-seed round led by Big Idea Ventures LLC, ProVeg International e.V. and...

Hummingbird and Synaffix in $150m ADC deal
Under the deal, Synaffix can earn up to $150m, including upfront and milestone payments, plus royalties on net sales if the ADC resulting from the...

First allogeneic cancer immunotherapy hits market
On December 20th, the European Commission approved Tabelecleucel (EbvalloTM) as a monotherapy for the treatment of adult and paediatric patients who...

Step Pharma presents promising cancer treatment
Since September 2022, STP938, the cancer inhibitor developed by Step Pharma SAS, has been undergoing clinical trials for the treatment of T and B...